-- Santhera Regains U.S., Canadian Rights to Fipamezole from Biovail in 2011
-- B y   C a r e y   S a r g e n t
-- 2010-10-25T05:04:25Z
-- http://www.bloomberg.com/news/2010-10-25/santhera-regains-u-s-canadian-rights-to-fipamezole-from-biovail-in-2011.html
Santhera Pharmaceuticals Holding
will regain U.S. and Canadian rights to the fipamezole medicine
from Biovail Laboratories as of January 2011, the company said
in a statement today.  To contact the editor responsible for this story:
Carey Sargent at 
 csargent3@bloomberg.net  